ORLANDO, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- PureCycle Technologies, Inc. (Nasdaq: PCT), a U.S.-based company revolutionizing plastic recycling, announced today a corporate update for the second quarter ending June 30, 2025. Management Commentary PureCycle CEO Dustin Olson commented, “We have begun to implement our growth plans following our successful $300 million capital raise that was executed in June. Our first expansion steps will be with facilities in Thailand and Belgium. Future facilities, beyon ...

- Refranchised 37 clinics; Franchises now represent 92% of the portfolio - - Acquired rights to the Northwest regional developer territory - SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, posted operating highlights and limited financial information for the quarter ended June 30, 2025. The following figures represent continuing operations unless otherwise stated. Q2 2025 Financial Highlights Grew rev ...

Realign priorities - AI-powered platforms to accelerate innovation and market leadership Driving transformation in pharmacy automation with VIVID’s advanced solutions Advancing AI-powered biomanufacturing with SBI’s DOTS Platform BOHEMIA, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Scientific Industries Inc. (OTCQB: SCND) (the “Company”) announced that it has sold its Genie Division to Troemner, LLC, a manufacturing sister company of OHAUS Corporation, (the “Buyer”) for $9.6 million in cash less working capital ...

Positive topline Phase 2a biomarker data position VTX3232 as a potential disease-modifying therapy for patients with Parkinson’s disease Data from the Phase 2 study of VTX2735 in patients with recurrent pericarditis expected in Q4 2025 Phase 2 study of VTX3232 in participants with obesity and cardiometabolic risk factors is fully-enrolled and on track to yield topline data in early Q4 2025 Cash, cash equivalents and marketable securities balance of $209.0M as of June 30, 2025 expected to fund planned operat ...

Revenue of $61 million, up 49%52% Member Growth and Significant Progress Toward Profitability SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Omada Health, Inc. (Nasdaq: OMDA), the virtual between-visit healthcare provider, today reported financial results for the second quarter ended June 30, 2025. 2025 Second Quarter Highlights Total Members of 752,000, up 52% compared to the second quarter of 2024Revenue of $61 million, up 49% compared to the second quarter of 2024GLP-1 Companion Success, with strong gr ...

Core Insights - RxSight, Inc. reported a total revenue of $33.6 million for Q2 2025, a 4% decrease from $34.9 million in Q2 2024, with LAL revenue increasing by 13% and LDD revenue decreasing by 50% [4][10] - The company aims to accelerate growth through enhanced customer engagement and strategic expansion of its installed base, supported by a newly launched Customer Success Organization [3] Financial Performance - Gross profit for Q2 2025 was $25.2 million, representing 74.9% of revenue, an increase from $24.3 million or 69.5% of revenue in Q2 2024 [5] - Total operating expenses for Q2 2025 were $39.2 million, a 20% increase from $32.6 million in Q2 2024, reflecting investments in LAL sales and R&D [6] - The net loss for Q2 2025 was $(11.8) million, or $(0.29) per share, compared to a net loss of $(6.1) million, or $(0.16) per share in Q2 2024 [7] Cash Position - Cash, cash equivalents, and short-term investments decreased by $1.8 million to $227.5 million as of June 30, 2025, compared to $229.3 million as of March 31, 2025 [8] Guidance - The company reiterated its 2025 full-year revenue guidance of $120.0 million to $130.0 million, indicating a decrease of 14% to 7% compared to 2024 [9][14]

NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- StepStone Group Inc. (Nasdaq: STEP), a global private markets investment firm focused on providing customized investment solutions and advisory and data services, today reported results for the quarter ended June 30, 2025. This represents results for the first quarter of the fiscal year ending March 31, 2026. The Board of Directors of the Company has declared a quarterly cash dividend of $0.28 per share of Class A common stock, payable on September 15, 2025, to th ...

Fiscal 2025 revenue grew 12.0%, fueled by 53% growth in Core IoT product sales Synaptics' Board of Directors approved a new share repurchase program of up to $150 million Fiscal 2025 Financial Highlights Revenue of $1.074 billion increased 12% year-over-yearCore IoT product sales grew by 53% year-over-yearGAAP loss per share of $1.22Non-GAAP diluted earnings per share increased 61% to $3.62Repurchased $128 million (or approximately 1.8 million) sharesReduced gross debt by approximately 14% or $134 million Q ...

Completed Merger with Logan Ridge Finance Corporation Reports Net Investment Income of $4.6 Million, or $0.50 Per Share for the Second Quarter Announces Third Quarter 2025 Quarterly Base Distribution of $0.47 Per Share and Supplemental Distribution of $0.02 per share NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Portman Ridge Finance Corporation (Nasdaq: PTMN) (the “Company” or “Portman Ridge”) announced today its financial results for the second quarter ended June 30, 2025. Transformational Milestone On July ...

Announced strategic partnership with Simcere Zaiming for Phase 1 program SIM0505 (CDH6 ADC) with plans to dose the first SIM0505 patient in the United States this quarter Currently in cohort 4 of the Phase 1 trial of LNCB74 (B7-H4 ADC) in multiple cancersPlan to provide SIM0505 and LNCB74 program updates by the fourth quarter of 2025, along with proof of concept data readouts in the first half of 2026 BELTSVILLE, Md., Aug. 07, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharm ...